BEONE MEDICINES Interim Net Profit Up 385.8% to USD464M; ADR Gains 0.7% PremarketAASTOCKS News·1 hour agoBGNE0.00%06160+2.24%
CSPC Pharma says FDA grants Fast Track status to SYS6090 for MSS/pMMR metastatic colorectal cancerPUBT·1 hour ago01093+1.22%
HANSOH PHARMA 1H26 Net Profit Up 35.8% YoY to RMB4.258B; Interim DPS Hiked 23% to HKD0.285AASTOCKS News·2 hours ago03692+0.51%
Hansoh Pharma FY26 H1 profit rises 35.8% to RMB 4.26 billion; revenue increases 11.7% to RMB 8.3 billionPUBT·2 hours ago03692+0.51%
Hong Kong stock movement: Performance exceeds expectations + Goldman Sachs upgrades rating, INNOVENT BIO rises 10.09%HK Stock Alerts·5 hours ago01801+9.69%
INNOVENT BIO Surges Over 8% as Results Beat Expectations; G Sachs and CLSA Raise TPAASTOCKS News·6 hours ago01801+9.69%
AKESO Ivonescimab Plus Chemotherapy Phase III Study Meets Primary Overall Survival EndpointAASTOCKS News·10 hours ago09926+5.96%
M Stanley Raises WUXI BIO TP to HKD57, 1H Results Beat ExpectationsAASTOCKS News·9 hours agoWXXWY+2.98%02269-2.78%
China’s Akeso Jumps After Phase III Trial Shows Its Novel Drug Plus Chemotherapy Beats Other BTC TreatmentsYicai·4 hours ago09926+5.96%MRK+3.84%
BeOne says FDA approves Tevimbra-based first-line regimen for HER2+ gastroesophageal cancerPUBT·21 hours agoBGNE0.00%06160+2.24%
Innovent Biologics: 2026H1 revenue and profit soared, driven by robust product growth and global expansionQuartr·22 hours ago01801+9.69%
Sinolink Securities Sticks to Its Buy Rating for Innovent Biologics (IVBXF)Tip Ranks·6 hours ago01801+9.69%
WuXi Biologics (Cayman) (SEHK:2269) Shares Climbed, So What Is Driving Attention Now?Simplywall·18 hours agoWXXWY+2.98%02269-2.78%
CSPC says FDA clears RSV vaccine candidate SYS 6057 for US clinical trialPUBT·1 day ago, 06:13 AM01093+1.22%300765+2.73%
Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Durvalumab Plus Chemotherapy in First-Line Advanced Biliary Tract Cancer in Single-Region Trial Conducted by Akeso in China | SMMT Stock NewsStockTitan·22 hours agoSMMT+4.95%09926+5.96%